Sign in
4

Changes in Ownership

OCULAR THERAPEUTIX, INC Filed Acc 0001104659-26-067478

Chief Strategy Officer sold 1,858 shares at $8.20 ($15,236)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Nayak Sanjay · Chief Strategy Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-05-26 Sale : show line 1 in the form 10b5-1 −1,858 $8.20 $15,236 328,795 D
Open-market sales · 1,858 sh · avg $8.20 · $15,236
Loading xslF345X06/tm2615856-1_4seq1.xml…